Click to watch the live stream and join the conversation. #PhRMA16

0 SHARES

0

0

0

6

0 SHARES

0

0

0

6

Fighting Diabetes


with innovative new medicines

Commitment to Research and Development


Matt Isn't Average


Fighting Rare Diseases


with innovative new medicines

We're Fighting Back


Patients and researchers are working together to fight disease.



Medicines in Development for Diabetes

More than 170 medicines are in development to offer the more than 30 million Americans suffering from diabetes longer, healthier lives.

Learn More



The biopharmaceutical industry

continues to be the most R&D-intensive industry in the U.S. economy, and PhRMA member companies are at the forefront. New data show PhRMA member companies invested $58.8 billion in research and development in 2015, up 10.3 percent from 2014.

Learn more



For Cancer Survivors Like Matt, Today is a New Opportunity

Today, with new treatments in the pipeline for cancer, patients and families have more hope than ever before. Learn more about Matt, as he highlights how participation in a clinical trial and innovation from America’s biopharmaceutical research companies has kept him alive.



Medicines in Development for Rare Diseases

More than 560 medicines are in development for rare diseases, including therapies for multiple myeloma, cystic fibrosis and ALS, providing treatment options for patients that had few or no treatment options before.

Learn more



Every Patient Has a Story

At 15 months old, Rhys was unusually tired. His pediatrician quickly figured out why: a tough combination of Type 1 diabetes and Celiac Disease. Fortunately, both can be managed with innovative medicines and diet. Today, Rhys is living the healthy, energetic childhood that every child deserves!

the latest

Get the latest blogs, policy papers, op-eds, and news on patients, innovative medicine development, health care, and more.


  • Translating science into new medicines

    Luciano Rossetti, M.D. explains the commitment it takes for researchers and scientists to achieve breakthroughs in cancer medicines.

    Read more
  • Arizona

    In the development of new medicines, clinical trials are conducted to prove therapeutic safety and effectiveness and compile the evidence needed for the Food and Drug Administration (FDA) to approve treatments.

    Read more
  • PhRMA's Dr. Chin talks about Diabetes

    PhRMA Executive VP and Chief Medical Officer William Chin M.D. talks about new and exciting therapies for diabetes.

    Read more
  • Fighting HIV/AIDS

    1.1 million Americans are living with HIV. Learn how the biopharmaceutical industry is fighting back with new medicines in development. #Hope2Cures

    Read more
  • I'm Not Average: Rhys

    Playing and learning all day exhausts most 15 month olds – and their parents. But little Rhys still seemed unusually tired, and his pediatrician discovered why: Type 1 diabetes and celiac disease. #ImNotAverage

    Read more

connect with PhRMA...

Make your voice heard. Join the important discussion on the value and economic impact of new medicines.


connect with PhRMA...

Make your voice heard. Join the important discussion on the value and economic impact of new medicines.


  • +68K

    Followers

  • +48K

    Followers

  • 378

    Followers

  • 1879

    Subscribers